ARCHIVES

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

This article is from The Cancer Letter archive.

Vol. 33 No. 45 | December 7, 2007

Download PDF Visit The Full Archive

Related Articles

New Approach To Replacing Immune Cells Shrinks Tumors

September 27, 2002

Report: Rising Treatment Costs Due to 340B Discounts

May 16, 2014

NCI Commits $8 Million More to R01s, Increases Payline to 12th Percentile. Surgeon General’s Report Says There’s No Safe Level of Secondhand Smoke.

June 30, 2006

DRCCA Board Okays Four Concepts, Rejects One, Tables Two Others

May 27, 1983

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

April 5, 2002

In Congress: Societies, Advocates, Testify For Increases In Research Funding

February 13, 1998